0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pertussis Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: August 2021
|
Report Code: QYRE-Othe-4136
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Pertussis Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Pertussis Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Othe-4136
Report
August 2021
116 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Global Pertussis Vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top five manufacturers hold a share over 90%. Europe is the largest market, with a share over 30%, followed by Asia-Pacific and North America, both have a share over 40% percent.
In terms of product, Acellular vaccines is the largest segment, with a share over 90%. And in terms of application, the largest application is Children, followed by Adults.
Market Analysis and Insights: Global Pertussis Vaccine Market

In 2020, the global Pertussis Vaccine market size was US$ 4987.3 million and it is expected to reach US$ 5518.8 million by the end of 2027, with a CAGR of 1.5% during 2021-2027.

Global Pertussis Vaccine Scope and Market Size
Pertussis Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Pertussis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Pertussis Vaccine market is segmented into

Whole-cell Vaccines
Acellular Vaccines

Segment by Application, the Pertussis Vaccine market is segmented into

Children
Adults
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape and Pertussis Vaccine Market Share Analysis
Pertussis Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Pertussis Vaccine product introduction, recent developments, Pertussis Vaccine sales by region, type, application and by sales channel.
The major companies include:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
1 Study Coverage
1.1 Pertussis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pertussis Vaccine Market Size Growth Rate by Type
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Market by Application
1.3.1 Global Pertussis Vaccine Market Size Growth Rate by Application
1.3.2 Children
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts
2.1.1 Global Pertussis Vaccine Revenue 2016-2027
2.1.2 Global Pertussis Vaccine Sales 2016-2027
2.2 Pertussis Vaccine Market Size by Region: 2021 Versus 2027
2.3 Pertussis Vaccine Sales by Region (2016-2027)
2.3.1 Global Pertussis Vaccine Sales by Region: 2016-2021
2.3.2 Global Pertussis Vaccine Sales Forecast by Region (2022-2027)
2.3.3 Global Pertussis Vaccine Sales Market Share by Region (2016-2027)
2.4 Pertussis Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Pertussis Vaccine Revenue by Region: 2016-2021
2.4.2 Global Pertussis Vaccine Revenue Forecast by Region (2022-2027)
2.4.3 Global Pertussis Vaccine Revenue Market Share by Region (2016-2027)
3 Global Pertussis Vaccine by Manufacturers
3.1 Global Top Pertussis Vaccine Manufacturers by Sales
3.1.1 Global Pertussis Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Pertussis Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Pertussis Vaccine Manufacturers by Revenue
3.2.1 Global Pertussis Vaccine Revenue by Manufacturer (2016-2021)
3.2.2 Global Pertussis Vaccine Revenue Share by Manufacturer (2016-2021)
3.3 Global Pertussis Vaccine Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Pertussis Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Pertussis Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Pertussis Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Pertussis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Pertussis Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Pertussis Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Corporation Information
4.1.2 Sanofi Pasteur Description, Business Overview
4.1.3 Sanofi Pasteur Pertussis Vaccine Products Offered
4.1.4 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Sanofi Pasteur Pertussis Vaccine Revenue by Product
4.1.6 Sanofi Pasteur Pertussis Vaccine Revenue by Application
4.1.7 Sanofi Pasteur Pertussis Vaccine Revenue by Geographic Area
4.1.8 Sanofi Pasteur Pertussis Vaccine Revenue by Sales Channel
4.1.9 Sanofi Pasteur Recent Development
4.2 GSK
4.2.1 GSK Corporation Information
4.2.2 GSK Description, Business Overview
4.2.3 GSK Pertussis Vaccine Products Offered
4.2.4 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.2.5 GSK Pertussis Vaccine Revenue by Product
4.2.6 GSK Pertussis Vaccine Revenue by Application
4.2.7 GSK Pertussis Vaccine Revenue by Geographic Area
4.2.8 GSK Pertussis Vaccine Revenue by Sales Channel
4.2.9 GSK Recent Development
4.3 Mitsubishi Tanabe Pharma
4.3.1 Mitsubishi Tanabe Pharma Corporation Information
4.3.2 Mitsubishi Tanabe Pharma Description, Business Overview
4.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
4.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue by Product
4.3.6 Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue by Application
4.3.7 Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue by Geographic Area
4.3.8 Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue by Sales Channel
4.3.9 Mitsubishi Tanabe Pharma Recent Development
4.4 Wuhan Institute of Biological Products
4.4.1 Wuhan Institute of Biological Products Corporation Information
4.4.2 Wuhan Institute of Biological Products Description, Business Overview
4.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
4.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Wuhan Institute of Biological Products Pertussis Vaccine Revenue by Product
4.4.6 Wuhan Institute of Biological Products Pertussis Vaccine Revenue by Application
4.4.7 Wuhan Institute of Biological Products Pertussis Vaccine Revenue by Geographic Area
4.4.8 Wuhan Institute of Biological Products Pertussis Vaccine Revenue by Sales Channel
4.4.9 Wuhan Institute of Biological Products Recent Development
4.5 Walvax Biotechnology
4.5.1 Walvax Biotechnology Corporation Information
4.5.2 Walvax Biotechnology Description, Business Overview
4.5.3 Walvax Biotechnology Pertussis Vaccine Products Offered
4.5.4 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Walvax Biotechnology Pertussis Vaccine Revenue by Product
4.5.6 Walvax Biotechnology Pertussis Vaccine Revenue by Application
4.5.7 Walvax Biotechnology Pertussis Vaccine Revenue by Geographic Area
4.5.8 Walvax Biotechnology Pertussis Vaccine Revenue by Sales Channel
4.5.9 Walvax Biotechnology Recent Development
4.6 Minhai Biotechnology
4.6.1 Minhai Biotechnology Corporation Information
4.6.2 Minhai Biotechnology Description, Business Overview
4.6.3 Minhai Biotechnology Pertussis Vaccine Products Offered
4.6.4 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Minhai Biotechnology Pertussis Vaccine Revenue by Product
4.6.6 Minhai Biotechnology Pertussis Vaccine Revenue by Application
4.6.7 Minhai Biotechnology Pertussis Vaccine Revenue by Geographic Area
4.6.8 Minhai Biotechnology Recent Development
5 Breakdown Data by Type
5.1 Global Pertussis Vaccine Sales by Type (2016-2027)
5.1.1 Global Pertussis Vaccine Sales by Type (2016-2021)
5.1.2 Global Pertussis Vaccine Sales Forecast by Type (2022-2027)
5.1.3 Global Pertussis Vaccine Sales Market Share by Type (2016-2027)
5.2 Global Pertussis Vaccine Revenue Forecast by Type (2016-2027)
5.2.1 Global Pertussis Vaccine Revenue by Type (2016-2021)
5.2.2 Global Pertussis Vaccine Revenue Forecast by Type (2022-2027)
5.2.3 Global Pertussis Vaccine Revenue Market Share by Type (2016-2027)
5.3 Pertussis Vaccine Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Pertussis Vaccine Sales by Application (2016-2027)
6.1.1 Global Pertussis Vaccine Sales by Application (2016-2021)
6.1.2 Global Pertussis Vaccine Sales Forecast by Application (2022-2027)
6.1.3 Global Pertussis Vaccine Sales Market Share by Application (2016-2027)
6.2 Global Pertussis Vaccine Revenue Forecast by Application (2016-2027)
6.2.1 Global Pertussis Vaccine Revenue by Application (2016-2021)
6.2.2 Global Pertussis Vaccine Revenue Forecast by Application (2022-2027)
6.2.3 Global Pertussis Vaccine Revenue Market Share by Application (2016-2027)
6.3 Pertussis Vaccine Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Pertussis Vaccine Market Size YoY Growth 2016-2027
7.2 North America Pertussis Vaccine Market Facts & Figures by Country
7.2.1 North America Pertussis Vaccine Sales by Country (2016-2027)
7.2.2 North America Pertussis Vaccine Revenue by Country (2016-2027)
7.3 North America Pertussis Vaccine Sales by Type
7.4 North America Pertussis Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Pertussis Vaccine Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Pertussis Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Pertussis Vaccine Sales by Region (2016-2027)
8.2.2 Asia-Pacific Pertussis Vaccine Revenue by Region (2016-2027)
8.3 Asia-Pacific Pertussis Vaccine Sales by Type
8.4 Asia-Pacific Pertussis Vaccine Sales by Application
9 Europe
9.1 Europe Pertussis Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Pertussis Vaccine Market Facts & Figures by Country
9.2.1 Europe Pertussis Vaccine Sales by Country (2016-2027)
9.2.2 Europe Pertussis Vaccine Revenue by Country (2016-2027)
9.3 Europe Pertussis Vaccine Sales by Type
9.4 Europe Pertussis Vaccine Sales by Application
10 Latin America
10.1 Latin America Pertussis Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Pertussis Vaccine Market Facts & Figures by Country
10.2.1 Latin America Pertussis Vaccine Sales by Country (2016-2027)
10.2.2 Latin America Pertussis Vaccine Revenue by Country (2016-2027)
10.3 Latin America Pertussis Vaccine Sales by Type
10.4 Latin America Pertussis Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Pertussis Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Pertussis Vaccine Sales by Country (2016-2027)
11.2.2 Middle East and Africa Pertussis Vaccine Revenue by Country (2016-2027)
11.3 Middle East and Africa Pertussis Vaccine Sales by Type
11.4 Middle East and Africa Pertussis Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Pertussis Vaccine Supply Chain Analysis
12.2 Pertussis Vaccine Key Raw Materials and Upstream Suppliers
12.3 Pertussis Vaccine Clients Analysis
12.4 Pertussis Vaccine Sales Channel and Sales Model Analysis
12.4.1 Pertussis Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Pertussis Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Pertussis Vaccine Distributors
13 Market Dynamics
13.1 Pertussis Vaccine Market Drivers
13.2 Pertussis Vaccine Market Opportunities
13.3 Pertussis Vaccine Market Challenges
13.4 Pertussis Vaccine Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Whole-cell Vaccines
    Table 3. Major Manufacturers of Acellular Vaccines
    Table 4. Global Pertussis Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 5. Global Pertussis Vaccine Market Size by Region (US$ Million): 2021 VS 2027
    Table 6. Global Pertussis Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 7. Global Pertussis Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
    Table 8. Global Pertussis Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 9. Global Pertussis Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 10. Global Pertussis Vaccine Sales by Manufacturer (2016-2021) & (M Doses)
    Table 11. Global Pertussis Vaccine Sales Share by Manufacturer (2016-2021)
    Table 12. Pertussis Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 13. Pertussis Vaccine Revenue Share by Manufacturer (2016-2021)
    Table 14. Key Manufacturers Pertussis Vaccine Price (2016-2021) & (USD/Doses)
    Table 15. Ranking of Global Top Pertussis Vaccine Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 17. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2020)
    Table 18. Pertussis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Pertussis Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Pertussis Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Sanofi Pasteur Corporation Information
    Table 23. Sanofi Pasteur Description and Business Overview
    Table 24. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 25. Sanofi Pasteur Pertussis Vaccine Product
    Table 26. Sanofi Pasteur Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
    Table 27. Sanofi Pasteur Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
    Table 28. Sanofi Pasteur Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 29. Sanofi Pasteur Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 30. Sanofi Pasteur Recent Development
    Table 31. GSK Corporation Information
    Table 32. GSK Description and Business Overview
    Table 33. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 34. GSK Pertussis Vaccine Product
    Table 35. GSK Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
    Table 36. GSK Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
    Table 37. GSK Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 38. GSK Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 39. GSK Recent Development
    Table 40. Mitsubishi Tanabe Pharma Corporation Information
    Table 41. Mitsubishi Tanabe Pharma Description and Business Overview
    Table 42. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 43. Mitsubishi Tanabe Pharma Pertussis Vaccine Product
    Table 44. Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
    Table 45. Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
    Table 46. Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 47. Mitsubishi Tanabe Pharma Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 48. Mitsubishi Tanabe Pharma Recent Development
    Table 49. Wuhan Institute of Biological Products Corporation Information
    Table 50. Wuhan Institute of Biological Products Description and Business Overview
    Table 51. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 52. Wuhan Institute of Biological Products Pertussis Vaccine Product
    Table 53. Wuhan Institute of Biological Products Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
    Table 54. Wuhan Institute of Biological Products Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
    Table 55. Wuhan Institute of Biological Products Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 56. Wuhan Institute of Biological Products Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 57. Wuhan Institute of Biological Products Recent Development
    Table 58. Walvax Biotechnology Corporation Information
    Table 59. Walvax Biotechnology Description and Business Overview
    Table 60. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 61. Walvax Biotechnology Pertussis Vaccine Product
    Table 62. Walvax Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
    Table 63. Walvax Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
    Table 64. Walvax Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 65. Walvax Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 66. Walvax Biotechnology Recent Development
    Table 67. Minhai Biotechnology Corporation Information
    Table 68. Minhai Biotechnology Description and Business Overview
    Table 69. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 70. Minhai Biotechnology Pertussis Vaccine Product
    Table 71. Minhai Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Product
    Table 72. Minhai Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Application
    Table 73. Minhai Biotechnology Pertussis Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 74. Minhai Biotechnology Recent Development
    Table 75. Global Pertussis Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 76. Global Pertussis Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
    Table 77. Global Pertussis Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 78. Global Pertussis Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 79. Global Pertussis Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 80. Global Pertussis Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
    Table 81. Global Pertussis Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 82. Global Pertussis Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 83. North America Pertussis Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 84. North America Pertussis Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 85. North America Pertussis Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 86. North America Pertussis Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 87. North America Pertussis Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 88. North America Pertussis Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 89. Asia-Pacific Pertussis Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 90. Asia-Pacific Pertussis Vaccine Sales by Region (2022-2027) & (M Doses)
    Table 91. Asia-Pacific Pertussis Vaccine Revenue by Region (2016-2027) & (US$ Million)
    Table 92. Asia-Pacific Pertussis Vaccine Revenue by Region (2022-2027) & (US$ Million)
    Table 93. Asia-Pacific Pertussis Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 94. Asia-Pacific Pertussis Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 95. Europe Pertussis Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 96. Europe Pertussis Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 97. Europe Pertussis Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 98. Europe Pertussis Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 99. Europe Pertussis Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 100. Europe Pertussis Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 101. Latin America Pertussis Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 102. Latin America Pertussis Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 103. Latin America Pertussis Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 104. Latin America Pertussis Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 105. Latin America Pertussis Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 106. Latin America Pertussis Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 107. Middle East and Africa Pertussis Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 108. Middle East and Africa Pertussis Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 109. Middle East and Africa Pertussis Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 110. Middle East and Africa Pertussis Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 111. Middle East and Africa Pertussis Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 112. Middle East and Africa Pertussis Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 113. Pertussis Vaccine Key Raw Materials, Industry Status and Trend
    Table 114. Pertussis Vaccine Key Raw Materials and Upstream Suppliers
    Table 115. Pertussis Vaccine Clients Status and Trend
    Table 116. Pertussis Vaccine Typical Clients
    Table 117. Pertussis Vaccine Distributors
    Table 118. Key Drivers: Impact Analysis (2022-2027)
    Table 119. Pertussis Vaccine Market Drivers
    Table 120. Pertussis Vaccine Market Opportunities
    Table 121. Pertussis Vaccine Market Challenges
    Table 122. Pertussis Vaccine Market Restraints
    Table 123. Pertussis Vaccine Porter’s Five Forces Analysis
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pertussis Vaccine Product Picture
    Figure 2. Global Pertussis Vaccine Sales Market Share by Type in 2021 & 2027
    Figure 3. Whole-cell Vaccines Product Picture
    Figure 4. Acellular Vaccines Product Picture
    Figure 5. Global Pertussis Vaccine Sales Market Share by Application in 2021 & 2027
    Figure 6. Children Examples
    Figure 7. Adults Examples
    Figure 8. Pertussis Vaccine Report Years Considered
    Figure 9. Global Pertussis Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Pertussis Vaccine Market Size 2016-2027 (US$ Million)
    Figure 11. Global Pertussis Vaccine Sales 2016-2027 (K Units)
    Figure 12. Global Pertussis Vaccine Market Size Market Share by Region: 2021 Versus 2027
    Figure 13. Global Pertussis Vaccine Sales Market Share Forecast by Region (2016-2027)
    Figure 14. Global Pertussis Vaccine Revenue Market Share by Region (2016-2027)
    Figure 15. Global Pertussis Vaccine Sales Share by Manufacturer in 2020
    Figure 16. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 17. Global Pertussis Vaccine Sales Market Share Forecast by Type (2016-2027)
    Figure 18. Global Pertussis Vaccine Revenue Market Share Forecast by Type (2016-2027)
    Figure 19. Pertussis Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 20. Global Pertussis Vaccine Sales Market Share Forecast by Application (2016-2027)
    Figure 21. Global Pertussis Vaccine Revenue Market Share Forecast by Application (2016-2027)
    Figure 22. Pertussis Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 23. North America Pertussis Vaccine Revenue 2016-2027 (US$ Million)
    Figure 24. North America Pertussis Vaccine Sales Market Share by Type (2016-2021)
    Figure 25. North America Pertussis Vaccine Sales Market Share by Application (2016-2021)
    Figure 26. Asia-Pacific Pertussis Vaccine Revenue 2016-2027 (US$ Million)
    Figure 27. Asia-Pacific Pertussis Vaccine Sales Market Share by Region (2016-2027)
    Figure 28. Asia-Pacific Pertussis Vaccine Revenue Market Share by Region (2016-2027)
    Figure 29. Asia-Pacific Pertussis Vaccine Sales Market Share by Type (2016-2021)
    Figure 30. Asia-Pacific Pertussis Vaccine Sales Market Share by Application (2016-2021)
    Figure 31. Europe Pertussis Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. Europe Pertussis Vaccine Sales Market Share by Country (2016-2027)
    Figure 33. Europe Pertussis Vaccine Revenue Market Share by Country (2016-2027)
    Figure 34. Europe Pertussis Vaccine Sales Market Share by Type (2016-2021)
    Figure 35. Europe Pertussis Vaccine Sales Market Share by Application (2016-2021)
    Figure 36. Latin America Pertussis Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 37. Latin America Pertussis Vaccine Sales Market Share by Country (2016-2027)
    Figure 38. Latin America Pertussis Vaccine Revenue Market Share by Country (2016-2021)
    Figure 39. Latin America Pertussis Vaccine Sales Market Share by Type (2016-2021)
    Figure 40. Latin America Pertussis Vaccine Sales Market Share by Application (2016-2021)
    Figure 41. Middle East and Africa Pertussis Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 42. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2016-2027)
    Figure 43. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2016-2027)
    Figure 44. Middle East and Africa Pertussis Vaccine Sales Market Share by Type (2016-2021)
    Figure 45. Middle East and Africa Pertussis Vaccine Sales Market Share by Application (2016-2021)
    Figure 46. Pertussis Vaccine Supply Chain (Upstream and Downstream Market)
    Figure 47. Global Production Market Share of Pertussis Vaccine Raw Materials by Region in 2020
    Figure 48. Pertussis Vaccine Distribution Channels
    Figure 49. Global Pertussis Vaccine Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 50. Global Pertussis Vaccine Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 51. Porter's Five Forces Analysis
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows multiple user to access the PDF.

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India